The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000662369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
4/05/2026
Date registered
Help: Date registered
4/06/2026
Date last updated
Help: Date last updated
4/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
4/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
From adversity to advancement: A co-designed group-based intervention for fostering posttraumatic growth among people with posttraumatic stress.
Scientific title
Pilot evaluation of a co-designed group-based intervention with a baseline stabilisation phase to promote posttraumatic growth among adults with trauma exposure
Additional trial identifiers [1] 315029 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Trauma 341756 0
Condition category
Condition code
Mental Health 337832 337832 0 0
Other mental health disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention is a co-designed, group-based psychological program aimed at fostering posttraumatic growth (PTG) in adults with a history of trauma exposure. The content of the intervention was developed through two phases of participatory co-design workshops. Phase 1 involved three workshops of two hours each with eight individuals with lived experience of trauma over a period of three weeks. Phase 2 involved two workshops of one hour each with six clinicians/researchers over a period of two weeks. This approach was to ensure that the program is both theoretically grounded and contextually relevant. The stakeholders in both phases were provided with sample program components and asked to provide feedback to refine the intervention content, delivery methods, and assessment procedures. The intervention focuses on facilitating positive psychological adaptation following trauma through structured activities targeting key domains of PTG, including meaning-making, cognitive processing, relational connection, personal strengths, and future orientation. The program incorporates psychoeducation, guided reflection, experiential exercises, and facilitated group discussions. The intervention is not designed to diagnose or treat mental disorders but to promote growth-oriented outcomes.
The intervention will be delivered by a trained facilitator who is an RCI (Rehabilitation Council of India) -licensed clinical psychologist from India and a provisional psychologist in training in Australia. The facilitator has prior experience working with individuals who have experienced trauma across diverse populations and mental health presentations. She has also been involved in previous research projects utilising co-design methodologies and is trained in trauma-informed approaches to group facilitation.
The intervention will be delivered in a small-group format with about 6-8 participants, allowing for peer interaction, shared reflection, and the development of interpersonal processes (e.g., validation and disclosure) that are relevant to PTG. Sessions are conducted face-to-face (hybrid/online if applicable), with a structured yet flexible format to accommodate participant needs.
The intervention will consist of 8–10 weekly sessions, with each session lasting approximately 120–150 minutes. Prior to the intervention, participants will complete a 4-week baseline stabilisation phase involving weekly assessments to establish a stable baseline of pre-intervention functioning. Outcome assessments continue during the intervention and at post-intervention and follow-up timepoints.
The intervention will be delivered in a university-based setting (Australian National University), providing a safe and confidential environment for group participation.
Participant adherence is supported through:

Regular session reminders (e.g., email and/or text message reminders)
Monitoring of session attendance and participation
Facilitator check-ins to support engagement and address barriers to attendance
Intervention fidelity will be maintained through the use of a structured intervention protocol with ongoing supervision by an AHPRA-registered clinical psychologist where required.


Intervention code [1] 333950 0
Behaviour
Description of the comparator or control
No separate control group. Participants act as their own controls using repeated measurements during a 4-week baseline stabilisation phase.
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345292 0
Posttraumatic growth
Timepoint [1] 345292 0
Three times during the baseline phase (weeks 0, 2, and 4), mid-intervention (week 8), post-intervention (week 12), and follow-up (3 months post-intervention).
Secondary outcome [1] 461187 0
Posttraumatic stress symptoms (PTSS)
Timepoint [1] 461187 0
Three times during the baseline phase (weeks 0, 2, and 4), mid-intervention (week 8), post-intervention (week 12), and follow-up (3 months post-intervention)
Secondary outcome [2] 461188 0
Deliberate ruminations
Timepoint [2] 461188 0
Three times during the baseline phase (weeks 0, 2, and 4), mid-intervention (week 8), post-intervention (week 12), and follow-up (3 months post-intervention)
Secondary outcome [3] 461189 0
Resilience
Timepoint [3] 461189 0
Three times during the baseline phase (weeks 0, 2, and 4), mid-intervention (week 8), post-intervention (week 12), and follow-up (3 months post-intervention)

Eligibility
Key inclusion criteria
Participants will be enrolled in the study based on the following inclusion criteria:
Are aged 18 years or older
Have lifetime exposure to at least one traumatic event
Can provide informed consent
Can participate in a group-based intervention
Have sufficient English proficiency to complete questionnaires and participate in group discussions
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants will be excluded from enrolling in the study based on the following exclusion criteria:
Are currently experiencing acute suicidality or imminent risk of harm to self or others
Are experiencing severe unmanaged mental health difficulties that would make group participation unsafe or inappropriate
Are unable to provide informed consent
Are unable to commit to the intervention schedule and assessment timepoints

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW

Funding & Sponsors
Funding source category [1] 319593 0
University
Name [1] 319593 0
School of Medicine and Psychology (SMP) Higher Degree by Research (HDR) funds provided by The Australian National University
Country [1] 319593 0
Australia
Primary sponsor type
University
Name
Australian National University
Address
Country
Australia
Secondary sponsor category [1] 322092 0
None
Name [1] 322092 0
Address [1] 322092 0
Country [1] 322092 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 318156 0
Australian National University Human Research Ethics Committee
Ethics committee address [1] 318156 0
Ethics committee country [1] 318156 0
Australia
Date submitted for ethics approval [1] 318156 0
20/05/2025
Approval date [1] 318156 0
10/11/2025
Ethics approval number [1] 318156 0
H/2025/0106

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 143294 0
A/Prof David Berle
Address 143294 0
Room 130, Building 39, School of Medicine and Psychology, Science Road, Australian National University, Acton, ACT, 2601.
Country 143294 0
Australia
Phone 143294 0
+61 2 6125 6337
Fax 143294 0
Email 143294 0
Contact person for public queries
Name 143295 0
Ritwika Nag
Address 143295 0
Room 210, Building 39, School of Medicine and Psychology, Science Road, Australian National University, Acton, ACT, 2601.
Country 143295 0
Australia
Phone 143295 0
+61 435896585
Fax 143295 0
Email 143295 0
Contact person for scientific queries
Name 143296 0
Ritwika Nag
Address 143296 0
Room 210, Building 39, School of Medicine and Psychology, Science Road, Australian National University, Acton, ACT, 2601.
Country 143296 0
Australia
Phone 143296 0
+61 435896585
Fax 143296 0
Email 143296 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.